Terug
Dagbereik
€ 41,73
€ 44,08
52-Weeksbereik
€ 10,91
€ 45,76
Volume
727.593
50D / 200D Gem.
€ 37,13
/
€ 24,94
Vorige Slotkoers
€ 41,25
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -16,6 | 0,4 |
| P/B | 3,6 | 2,9 |
| ROE % | -25,2 | 3,8 |
| Net Margin % | — | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 48,33
+13.0%
Low: € 43,00
High: € 53,00
Forward WPA
-€ 2,92
Omzet Sch.
89000
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
-€ 3,87
-€ 3,87 – -€ 3,87
|
92 M | 6 |
| FY2029 |
-€ 3,67
-€ 3,67 – -€ 3,67
|
38 M | 6 |
| FY2028 |
-€ 3,32
-€ 4,67 – -€ 2,48
|
200000 | 8 |
Belangrijkste Punten
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -169,25M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-25,17%
ROIC-21,97%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,00
Current Ratio13,25
Interest Coverage0,00
Waardering
P/E Ratio
-16,64
P/B Ratio3,61
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -155,20M |
| ROE | -25,17% | ROA | -19,95% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -169,25M |
| ROIC | -21,97% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 13,25 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -16,64 | P/B Ratio | 3,61 |
| P/S Ratio | N/A | PEG Ratio | 1,94 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 2,58B | Enterprise Value | 2,50B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 886.000,0 | 2,33M | 18,74M |
| Net Income | -155,20M | -208,02M | -338,79M | -83,82M | -65,80M |
| EPS (Diluted) | -1,98 | -3,18 | -46,15 | -24,86 | -25,02 |
| Gross Profit | -171,65M | 0,0 | 886.000,0 | 2,33M | 18,74M |
| Operating Income | -209,56M | -208,57M | -242,30M | -84,78M | -65,65M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 777,78M | 608,48M | 341,86M | 71,14M | 109,93M |
| Total Liabilities | 62,55M | 90,68M | 157,84M | 20,84M | 25,99M |
| Shareholders' Equity | 715,24M | 517,80M | 184,02M | 50,31M | 83,94M |
| Total Debt | 0,0 | 0,0 | 0,0 | 4,63M | 5,06M |
| Cash & Equivalents | 85,72M | 89,42M | 188,89M | 34,86M | 15,14M |
| Current Assets | 777,78M | 608,47M | 341,53M | 62,26M | 98,89M |
| Current Liabilities | 58,69M | 54,06M | 31,98M | 14,66M | 20,14M |